Similar to the effects of Shikonin, TEPP‐46 attenuated kidney α‐SMA expression during AKI‐CKD (Figure 5F) and ameliorated renal tissue fibrosis (Figure 5G). This evidence concerns the gene SPMIP8 and acute kidney injury.